Search Results

There are 26429 results for: content related to: Dysphagia in multiple sclerosis – prevalence and prognostic factors

  1. Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data

    Acta Neurologica Scandinavica

    Volume 111, Issue 1, January 2005, Pages: 42–47, K. P. Johnson, C. C. Ford, R. P. Lisak and J. S. Wolinsky

    Article first published online : 9 DEC 2004, DOI: 10.1111/j.1600-0404.2004.00351.x

  2. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality

    Acta Neurologica Scandinavica

    Volume 110, Issue 1, July 2004, Pages: 6–13, I. S. Lobentanz, S. Asenbaum, K. Vass, C. Sauter, G. Klösch, H. Kollegger, W. Kristoferitsch and J. Zeitlhofer

    Article first published online : 13 APR 2004, DOI: 10.1111/j.1600-0404.2004.00257.x

  3. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 105, Issue 3, March 2002, Pages: 164–168, T. Patzold, M. Schwengelbeck, L.-M. Ossege, J.-P. Malin and E. Sindern

    Article first published online : 8 MAR 2002, DOI: 10.1034/j.1600-0404.2002.1o135.x

  4. Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 105, Issue 4, April 2002, Pages: 300–308, J. Kraus, B. S. Kuehne, J. Tofighi, P. Frielinghaus, E. Stolz, F. Blaes, C. Laske, B. Engelhardt, H. Traupe, M. Kaps and P. Oschmann

    Article first published online : 3 APR 2002, DOI: 10.1034/j.1600-0404.2002.1o199.x

  5. Clinical benefits of interferon beta-1a in relapsing–remitting MS: a phase IV study

    Acta Neurologica Scandinavica

    Volume 107, Issue 1, January 2003, Pages: 7–11, O. Fernández, T. Arbizu, G. Izquierdo, A. Martínez-Yélamos, J. M. Gata, G. Luque and E. De Ramón

    Article first published online : 14 JAN 2003, DOI: 10.1034/j.1600-0404.2003.01350.x

  6. You have free access to this content
    Physical inactivity, neurological disability, and cardiorespiratory fitness in multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 123, Issue 2, February 2011, Pages: 98–104, R. W. Motl and M. Goldman

    Article first published online : 17 MAY 2010, DOI: 10.1111/j.1600-0404.2010.01361.x

  7. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants

    Acta Neurologica Scandinavica

    Volume 119, Issue 2, February 2009, Pages: 126–130, M. Vercellino, A. Romagnolo, A. Mattioda, S. Masera, C. Piacentino, A. Merola, A. Chiò, R. Mutani and P. Cavalla

    Article first published online : 5 AUG 2008, DOI: 10.1111/j.1600-0404.2008.01076.x

  8. Psychometric properties of a Norwegian version of Multiple Sclerosis Impact Scale (MSIS-29)

    Acta Neurologica Scandinavica

    Volume 122, Issue 4, October 2010, Pages: 244–251, T. Smedal, H. H. Johansen, K.-M. Myhr and L. I. Strand

    Article first published online : 23 NOV 2009, DOI: 10.1111/j.1600-0404.2009.01298.x

  9. Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study

    Acta Neurologica Scandinavica

    Volume 126, Issue 5, November 2012, Pages: 306–314, R. Lanzillo, M. Quarantelli, S. Bonavita, G. Ventrella, G. Lus, G. Vacca, A. Prinster, G. Orefice, G. Tedeschi and V. Brescia Morra

    Article first published online : 23 NOV 2011, DOI: 10.1111/j.1600-0404.2011.01622.x

  10. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners

    Acta Neurologica Scandinavica

    Volume 108, Issue 6, December 2003, Pages: 389–395, A. C. J. W. Janssens, P. A. van Doorn, J. B. de Boer, F. G. A. van der Meché, J. Passchier and R. Q. Hintzen

    Article first published online : 12 SEP 2003, DOI: 10.1034/j.1600-0404.2003.00166.x

  11. Increased disability and MRI lesions after discontinuation of IFN-β-1a in secondary progressive MS

    Acta Neurologica Scandinavica

    Volume 112, Issue 4, October 2005, Pages: 242–247, X. Wu, P. Dastidar, H. Kuusisto, M. Ukkonen, H. Huhtala and I. Elovaara

    Article first published online : 2 SEP 2005, DOI: 10.1111/j.1600-0404.2005.00477.x

  12. Glatiramer acetate in treatment-naïve and prior interferon-β-1b-treated multiple sclerosis patients

    Acta Neurologica Scandinavica

    Volume 113, Issue 6, June 2006, Pages: 378–386, H. L. Zwibel

    Article first published online : 21 APR 2006, DOI: 10.1111/j.1600-0404.2006.00627.x

  13. Antibodies against light neurofilaments in multiple sclerosis patients

    Acta Neurologica Scandinavica

    Volume 116, Issue 2, August 2007, Pages: 100–107, A. Bartoš, L. Fialová, J. Soukupová, J. Kukal, I. Malbohan and J. Piťha

    Article first published online : 26 JUL 2007, DOI: 10.1111/j.1600-0404.2006.00794.x

  14. Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk

    Acta Neurologica Scandinavica

    Volume 103, Issue 1, January 2001, Pages: 20–26, M. Pugliatti, S. Sotgiu, G. Solinas, P. Castiglia, M. I. Pirastru, B. Murgia, L. Mannu, G. Sanna and G. Rosati

    Article first published online : 20 DEC 2001, DOI: 10.1034/j.1600-0404.2001.00207.x

  15. Intrathecal IgG synthesis: marker of progression in multiple sclerosis patients

    Acta Neurologica Scandinavica

    Volume 105, Issue 3, March 2002, Pages: 158–163, G. Izquierdo, S. Angulo, J. M. Garcia-Moreno, M. A. Gamero, G. Navarro, J. M. Gata, J. L. Ruiz-Peña and M. D. Páramo

    Article first published online : 8 MAR 2002, DOI: 10.1034/j.1600-0404.2002.1o009.x

  16. Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 115, Issue 5, May 2007, Pages: 325–330, M. Terzi, A. Birinci, E. Çetinkaya and M. K. Onar

    Article first published online : 3 MAY 2007, DOI: 10.1111/j.1600-0404.2007.00782.x

  17. Fas expression on T cells and sFas in relapsing-remitting multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 107, Issue 6, June 2003, Pages: 387–393, M. Bilinska, I. Frydecka, R. Podemski and E. Gruszka

    Article first published online : 20 MAY 2003, DOI: 10.1034/j.1600-0404.2003.00002.x

  18. CD45RA+ ICAM-3+ lymphocytes in interferon-β1b-treated and -untreated patients with relapsing–remitting multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 110, Issue 6, October 2004, Pages: 377–385, N. Chatzimanolis, J. Kraus, R. Bauer, B. Engelhardt, T. Bregenzer, B. S. Kuehne, J. Tofighi, C. Laske, E. Stolz, F. Blaes, K. Voigt, H. Traupe, M. Kaps and P. Oschmann

    Article first published online : 4 NOV 2004, DOI: 10.1111/j.1600-0404.2004.00346.x

  19. Cognitive correlates of supratentorial atrophy on MRI in multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 104, Issue 4, October 2001, Pages: 214–223, S. G. M. Edwards, C. Liu and L. D. Blumhardt

    Article first published online : 20 DEC 2001, DOI: 10.1034/j.1600-0404.2001.00270.x

  20. Illness perception and health-related quality of life in multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 116, Issue 5, November 2007, Pages: 293–299, L. A. Spain, N. Tubridy, T. J. Kilpatrick, S. J. Adams and A. C. N. Holmes

    Article first published online : 11 SEP 2007, DOI: 10.1111/j.1600-0404.2007.00895.x